Eileen McDermott quoted from our recent report on ‘Will the USMCA’s Requirements on Regulatory Data Protection increase spending on Medicines’ in an article at IPWatchdog. Post navigation Previous Article Previous Article Geneva Network at the 2019 Summit of the Global Trade and Innovation Policy Alliance Next Article Next Article CodeBlue Reports on Improving Access to Medicines You may also like Why Voluntary Licensing is Best for Increasing Access to Medicines News Reforming Indonesia’s 2016 patent act News
